Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Dec 03, 2021 12:51pm
158 Views
Post# 34195515

It is clear they stopped q&a since they don’t want to face q

It is clear they stopped q&a since they don’t want to face q

Questions from retail investors and and don't want truth to come out  and are afraid of getting into more legal problems THEIR LAWYER PROBABLY ADVISED THEM NOT TO HAVE Q&a during quarterly updates 

I don't know can they legally not have q&a ,
what will they answer under oath. If lawyers ask them why did you have q&a since beginning and now you stopped letting retail investors and analyst ask questions like.  WHY DID YOU STOP R&D RE 4050
why did you sell plasma division and voucher few weeks before fda approval  
why did you stop alstrom study which was showing great results and would be data proof of concept 
why did you get rid of your top scientist Lynne gagnon and John Moran 
why did you state we exhausted all avenues to raise money and as soon as they took over company and wiping out retail investors you raised 38 million with short period when confidence was at its lowest   


 

<< Previous
Bullboard Posts
Next >>